P

Inventor

KUTSCHER SARAH

DE11 patents

Patents

11 patents
US11786583B2Oct 17, 2023

Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers

IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US11679147B2Jun 20, 2023

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US11672848B2Jun 13, 2023

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US11576956B2Feb 14, 2023

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

IMMATICS BIOTECHNOLOGIES GMBH2 citations73
US12121572B2Oct 22, 2024

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12097248B2Sep 24, 2024

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12076380B2Sep 3, 2024

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12070491B2Aug 27, 2024

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11779638B2Oct 10, 2023

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11559573B2Jan 24, 2023

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11406693B2Aug 9, 2022

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62